Why the study?
hnRNPs play important roles in modulating host innate immunity against viral infection, with novel findings suggesting their potential utility in antiviral therapies.
This review highlights the role of hnRNPs in antiviral innate immunity and their potential as targets for novel antiviral therapies.
May inform viral myocarditis research; leaves open clinical relevance pending targeted trials.
During virus infection, many host proteins are redirected from their normal cellular roles to restrict and terminate infection. Heterogeneous nuclear ribonucleoproteins (hnRNPs) are cellular RNA-binding proteins critical to host nucleic acid homeostasis, but can also be involved in the viral infection process, affecting virus replication, assembly and propagation. It has become evident that hnRNPs play important roles in modulation of host innate immunity, which provides critical initial protection against infection. These novel findings can potentially lead to the leveraging of hnRNPs in antiviral therapies. We review hnRNP involvement in antiviral innate immunity, in humans, mice and other animals, and discuss hnRNP targeting as a potential novel antiviral therapeutic.
No takes yet. Share an insight, caveat, or question.
Maceratessi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: